Table 3.
“Bridging-to-surgery” period, comparison of T1 (first visit) and T2 (pre-operative visit)
| First visit (T1)* | Pre-operative (T2)* | p value | |
|---|---|---|---|
| Primary outcome$ | 26 (28.0%) | 62 (66.7%) | <0.0001 |
| Living situation | |||
|
At home Hospital Rehabilitation home |
53 (57.0%) 33 (35.5%) 7 (7.5%) |
79 (84.9%) 8 (8.6%) 6 (6.5%) |
< 0.0001 < 0.001 0.220 |
| Oral intake | 59 (63.4%) | 87 (93.5%) | < 0.0001 |
| Albumin > 35 g/L | 51 (54.8%) | 71 (76.3%) | < 0.0001 |
| Weight loss (kg)1 | 6.5 (IQR 1-12) | 3 (IQR 0-8) | < 0.0001 |
| BMI (kg/m2) | 23.2 (IQR 20.5-26.4) | 24.2 (IQR 22.0-27.1) | < 0.0001 |
| Parenteral administration | |||
|
Patients with only PN PN administration per week (mL) Patients with only fluids Fluid administration per week (mL) Patients with PN and fluids PN administration per week (mL) Fluid administration per week (mL) |
36 (38.7%) 14000 (11944–14000) 6 (6.5%) 10500 (7000–17500) 44 (47.3%) 12250 (10500–14000) 7000 (5688–10500) |
13 (14.0%) 11760 (10500–14000) 11 (11.8%) 10500 (7000–14000) 56 (60.2%) 10500 (7000–14000) 7000 (5250–10500) |
|
| Medication | |||
|
PPI Loperamide Somatostatin analogue Codeine |
73 (78.5%) 40 (43.0%) 15 (16.1%) 20 (21.5%) |
78 (83.9%) 48 (51.6%) 16 (17.2%) 15 (16.1%) |
|
*Values in median (IQR)
$Primary outcome = living situation at home + oral intake + albumin > 35 g/L
1Compared with preadmission body weight